Alkermes plc. (ALKS): Depreciation & Amortization
$27.16M
Year ended 2025-12-31
$61.63M
Trailing 12 months to 2026-06-30
-29.6%
3-year compound annual growth
-19.8%
5-year compound annual growth
-10.8%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.16M | -4.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $28.53M | -61.9% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $74.93M | -3.8% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $77.86M | -1.0% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $78.65M | -3.9% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $81.85M | +1.8% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $80.41M | -22.4% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $103.66M | +5.2% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $98.52M | +4.5% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $94.26M | +10.1% | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | $85.60M | -12.7% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $98.09M | n/a | 2017-02-17, From 2014-01-01 |
| No annual figure between 2013-03-31 and 2014-12-31. | |||
| 2013-03-31 | $73.75M | +54.0% | 2015-02-24, From 2012-04-01 |
| 2012-03-31 | $47.88M | +453.4% | 2013-05-23, From 2011-04-01 |
| 2011-03-31 | $8.65M | -65.4% | 2013-05-23, From 2010-04-01 |
| 2010-03-31 | $25.03M | n/a | 2012-05-18, From 2009-04-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $27.16M | -4.8% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $51.51M | +13.0% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $38.81M | -48.7% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $10.00M | -37.5% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $31.27M | +3.6% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $44.52M | +18.0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $1.51M | +37.4% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $91.42M | +35.0% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.20M | +31.4% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗